RecruitingNot ApplicableNCT07679945

A Clinical Study to Evaluate the Efficacy in Improving Dark Spots After 8 Weeks of Use of Facial Sunscreens in Adult Participants

A Monocentric and Open-Label Clinical Study to Evaluate the Efficacy in Improving Dark Spots After 8 Weeks of Use of Facial Sunscreens in Adult Research Participants


Sponsor

Kenvue Brands LLC

Enrollment

152 participants

Start Date

Jun 2, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The study aims to evaluate the efficacy of a facial sunscreen under two experimental conditions-untinted and tinted-in improving facial spots (melasma and solar lentigines/post-inflammatory hyperpigmentation) after 8 weeks of product use under normal conditions by adult participants.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Sunscreen tinted and Sunscreen untinted for people with melasma, post-inflammatory hyperpigmentation, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSunscreen untinted

Participants will apply the facial sunscreen on the face at least twice daily for 56 days

OTHERSunscreen tinted

Participants will apply the facial sunscreen on the face at least twice daily for 56 days


Locations(1)

ALS Beauty & Personal Care Ltda

Campinas, São Paulo, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07679945


Related Trials